beta-thujaplicin and Uterine Cervical Neoplasms

beta-thujaplicin has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, BK; Chen, LC; Chen, PH; Wang, CC	1

Other Studies

1 other study(ies) available for beta-thujaplicin and Uterine Cervical Neoplasms

Article	Year
Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma. Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Epidermal Growth Factor; Female; HeLa Cells; Humans; Monoterpenes; Tropolone; Uterine Cervical Neoplasms	2020

Article

Year

Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.

Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:5

Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Epidermal Growth Factor; Female; HeLa Cells; Humans; Monoterpenes; Tropolone; Uterine Cervical Neoplasms

2020